An interventional study of Pre-Conditioning Functional Resistance Exercise Program in Sarcopenia in Elderly, sponsored by University of Hull. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-08-11.
Sponsored by University of Hull · Not applicable, Interventional, and Treatment
This study aims to assess whether a short, structured exercise programme is suitable and acceptable for older adults with early-stage muscle weakness (known as probable sarcopenia). Sarcopenia is a common condition associated with ageing that leads to reduced muscle strength, mobility, and independence, increasing the risk of falls, hospitalisation, and reduced quality of life.
Exercise, particularly resistance training, is recommended as the first-line treatment for sarcopenia. However, many programmes require participants to begin at relatively high levels of intensity, which may be challenging for individuals with low baseline strength or confidence. A short "pre-conditioning" phase of exercise may help prepare individuals physically and improve their ability to safely engage in more structured training in the future.
This study will investigate an 8-week functional resistance training (FRT) programme designed to improve movement ability, strength, and confidence using exercises that mimic everyday activities such as standing, stepping, and lifting. Participants will be randomly assigned to complete the same programme either in a supervised and clinic-based setting or independently and home-based setting following instruction and guidance.
The main aim of the study is to determine whether this type of programme is feasible and acceptable, including whether participants are willing to take part, attend sessions, and complete the programme safely. The study will also explore whether the programme may lead to improvements in physical function, strength, and quality of life.
1,329 studies on the registry are indexed under Sarcopenia; 420 are open to participants now.
This study's planned enrollment of 30 is below the median of 60 across 855 interventional studies indexed under Sarcopenia.
Browse Sarcopenia studies →University of Hull is the lead sponsor of 35 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Pre-Conditioning Functional Resistance Exercise Program
Other: Pre-Conditioning Functional Resistance Exercise Program
The intervention will consist of an 8-week pre-conditioning functional resistance training (FRT) programme, delivered twice weekly (30-60-minute sessions). Participants will be allocated to one of two groups: a supervised clinic-based exercise group or a home-based exercise group. The programme will focus on multi-joint, task-oriented movements designed to replicate activities of daily living and improve functional capacity. Exercise intensity and volume will be prescribed using an autoregulated approach based on Borg CR Scale ® (Borg CR10) Rating of Perceived Exertion (RPE), allowing participants to adjust training in response to daily fatigue and readiness. Clinic-based sessions will be supervised and progressed by the Chief Investigator, while home-based participants will perform the same prescribed exercises independently following initial instruction, with ongoing support and monitoring provided throughout the intervention period.
Recruitment rate, eligibility rate, randomisation acceptability, adherence, retention rate and acceptability
Recruitment rate, eligibility rate, randomisation acceptability, adherence, retention rate and acceptability of the exercise programme completed both in clinic, and at home.
Time frame: From enrolment to the end of treatment at 8 weeks
Muscle mass via Bioelectrical Impedance Analysis
Time frame: From enrolment until the end of the 8-week intervention period
Grip Strength with Hand Dynomometer
Time frame: From enrolment until the end of the 8-week intervention period
Gait Speed over 4m
Reported in m/s.
Time frame: From enrolment until the end of the 8-week intervention period
EQ-5D-5L
Quality of life questionnaire
Time frame: From enrolment until the end of the 8-week intervention period
Short Physical Performance Battery
Scored in line with the European Working Group on Sarcopenia (EWGSOP2) criteria
Time frame: From enrolment until the end of the 8-week intervention period
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Aug 2026; primary completion for Feb 2027, 6 months later.
Of 492 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's planned 6 months is below that.
Counting every sponsor, half of 503 studies reached it within 18 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Hull